[go: up one dir, main page]

FI922655A0 - Foerfarande foer framstaellning av av faktor beroende human b-cell-linjer. - Google Patents

Foerfarande foer framstaellning av av faktor beroende human b-cell-linjer.

Info

Publication number
FI922655A0
FI922655A0 FI922655A FI922655A FI922655A0 FI 922655 A0 FI922655 A0 FI 922655A0 FI 922655 A FI922655 A FI 922655A FI 922655 A FI922655 A FI 922655A FI 922655 A0 FI922655 A0 FI 922655A0
Authority
FI
Finland
Prior art keywords
cell
human
cross
linjer
beroende
Prior art date
Application number
FI922655A
Other languages
English (en)
Other versions
FI922655A7 (fi
Inventor
Jacques Banchereau
Francoise Rousset
Original Assignee
Schering Plough Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Corp filed Critical Schering Plough Corp
Publication of FI922655A7 publication Critical patent/FI922655A7/fi
Publication of FI922655A0 publication Critical patent/FI922655A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Control Of El Displays (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Silicon Polymers (AREA)
  • Materials For Medical Uses (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Light Receiving Elements (AREA)
  • Peptides Or Proteins (AREA)
FI922655A 1989-12-14 1990-12-13 Foerfarande foer framstaellning av av faktor beroende human b-cell-linjer. FI922655A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19890403491 EP0434879A1 (en) 1989-12-14 1989-12-14 Method of making factor dependent human B cell lines
PCT/EP1990/002195 WO1991009115A1 (en) 1989-12-14 1990-12-13 Method of making factor-dependent human b cell lines

Publications (2)

Publication Number Publication Date
FI922655A7 FI922655A7 (fi) 1992-06-09
FI922655A0 true FI922655A0 (fi) 1992-06-09

Family

ID=8203014

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922655A FI922655A0 (fi) 1989-12-14 1990-12-13 Foerfarande foer framstaellning av av faktor beroende human b-cell-linjer.

Country Status (16)

Country Link
EP (2) EP0434879A1 (fi)
JP (1) JPH0789910B2 (fi)
AT (1) ATE135041T1 (fi)
AU (1) AU655759B2 (fi)
CA (1) CA2071886A1 (fi)
DE (1) DE69025772T2 (fi)
ES (1) ES2084146T3 (fi)
FI (1) FI922655A0 (fi)
IE (1) IE904498A1 (fi)
IL (1) IL96639A0 (fi)
MY (1) MY106561A (fi)
NO (1) NO922332D0 (fi)
NZ (1) NZ236425A (fi)
OA (1) OA09701A (fi)
WO (1) WO1991009115A1 (fi)
ZA (1) ZA909778B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874082A (en) * 1992-07-09 1999-02-23 Chiron Corporation Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
AU5098493A (en) * 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
EP0619323A1 (en) * 1993-04-09 1994-10-12 Schering-Plough Human monoclonal antibodies and processes and materials for making such antibodies
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
EP0659766A1 (en) * 1993-11-23 1995-06-28 Schering-Plough Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
MX9605088A (es) 1994-04-28 1997-08-30 Boehringer Ingelheim Pharma Metodos para proliferar y diferenciar celulas b y sus usos.
US6465251B1 (en) * 1996-11-13 2002-10-15 Dana-Farber Cancer Institute, Inc. Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
EP1033406A4 (en) * 1997-10-27 2005-03-09 Sumitomo Electric Industries INDUCER FOR THE PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODY, EXPRESSION VECTOR CONTAINING THE GENE REQUIRED THEREFOR, AND METHOD FOR INDUCING THE PRODUCTION OF THE ANTIGEN-SPECIFIC ANTIBODY
US7063845B2 (en) 2000-04-28 2006-06-20 Gemini Science, Inc. Human anti-CD40 antibodies
DE60143535D1 (de) 2000-10-02 2011-01-05 Novartis Vaccines & Diagnostic Humane antikörper gegen cd40
PT1391464E (pt) 2001-04-27 2007-11-15 Kirin Pharma Kk Anticorpo monoclonal anti-cd40
AU2004215125B2 (en) * 2003-02-26 2011-01-06 Institute For Research In Biomedicine Monoclonal antibody production by EBV transformation of B cells
GB2398783A (en) 2003-02-26 2004-09-01 Antonio Lanzavecchia A method for producing immortalised human B memory lymphocytes
DE602006014691D1 (de) 2005-08-02 2010-07-15 Xbiotech Inc DIAGNOSE, BEHANDLUNG UND PRÄVENTION VON GEFÄSSERKRANKUNGEN MITTELS IL-1alpha-AUTOANTIKÖRPERN
JP5762408B2 (ja) 2009-08-13 2015-08-12 クルセル ホランド ベー ヴェー ヒト呼吸器合胞体ウイルス（ｒｓｖ）に対する抗体および使用方法
EP2316920A1 (en) * 2009-10-30 2011-05-04 BioNTech AG Clonal expansion of B cells
TWI539963B (zh) 2010-07-09 2016-07-01 庫賽爾荷蘭公司 抗－人類呼吸道融合性病毒（ｒｓｖ）抗體及其使用方法
JP2014518080A (ja) 2011-06-27 2014-07-28 バルネバ 細胞のスクリーニング方法

Also Published As

Publication number Publication date
EP0505397B1 (en) 1996-03-06
CA2071886A1 (en) 1991-06-15
NZ236425A (en) 1993-02-25
FI922655A7 (fi) 1992-06-09
NO922332L (no) 1992-06-12
NO922332D0 (no) 1992-06-12
WO1991009115A1 (en) 1991-06-27
DE69025772T2 (de) 1997-02-06
MY106561A (en) 1995-06-30
JPH05503214A (ja) 1993-06-03
IE904498A1 (en) 1991-06-19
JPH0789910B2 (ja) 1995-10-04
IL96639A0 (en) 1991-09-16
AU6901791A (en) 1991-07-18
ZA909778B (en) 1991-10-30
OA09701A (en) 1993-08-30
EP0505397A1 (en) 1992-09-30
AU655759B2 (en) 1995-01-12
EP0434879A1 (en) 1991-07-03
ATE135041T1 (de) 1996-03-15
DE69025772D1 (de) 1996-04-11
ES2084146T3 (es) 1996-05-01

Similar Documents

Publication Publication Date Title
FI922655A0 (fi) Foerfarande foer framstaellning av av faktor beroende human b-cell-linjer.
AU4055697A (en) Mammalian cell surface antigens; related reagents
AU2508492A (en) Sirs vaccine and diagnosis method
WO1998027114A3 (en) Mammalian cell surface antigens; related reagents
JPS6447378A (en) Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
ES8706964A1 (es) Un procedimiento para fraccionar anticuerpos de suero.
ATE171193T1 (de) Tumorantigen-spezifischer antikörper
AU5697098A (en) Mammalian cell surface antigens; related reagents
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
IE46215L (en) Gamma-globulins, immune nucleic acids and immune dialysates.
ATE67313T1 (de) Nachweis von menschlichem cytomegalovirusspezifischem igm.
AU525403B2 (en) Purified antigen
AU564575B2 (en) Polyvalent endotoxin specific antibodies
EP0323802A3 (en) Monoclonal antibodies against, and cell surface antigen of, lung carcinoma
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
EP1867720A3 (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ES2047946T3 (es) Metodos de cultivos celulares para producir proteina c activada.
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
EP0089771A3 (en) Atcc hb8116 and its monoclonal anti-h-y antibody, hyclonalan
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
SU1398393A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus, используемый для получения моноклональных антител к микобактериям туберкулеза

Legal Events

Date Code Title Description
FD Application lapsed